Loading…
We use essential cookies (authentication, your saved goals/stack) by default. With your permission we'll also enable privacy-respecting analytics (Vercel Web Analytics, anonymous load-time metrics) and error-replay diagnostics (Sentry — DOM snapshots only when an error fires) so we can fix bugs faster. Learn more about cookies
Head-to-head evidence comparison — which supplement is right for you?
Omega-3 wins 3 of 3 categories. Both are solid choices — the best pick depends on your specific goals.
Verdict
Probably helps
5 of 8 studies with measurable effects showed benefit.
Top outcomes
Verdict
Probably helps
18 of 27 studies with measurable effects showed benefit.
Top outcomes
Shared outcomes (1)
Outcomes where both Biotin and Omega-3 have evidence — compare verdict strength side-by-side.
2500-5000mcg (2.5-5mg) for hair/nails
Any time of day
Biotin capsules or tablets
2-3g combined EPA+DHA daily
With meals containing fat
Triglyceride form fish oil
3-6 months
3-6 months
4-8 weeks
2-4 weeks
Immediate
4-12 weeks
Quantitative comparison of the efficacy of clinical drug treatments for primary progressive multiple sclerosis
Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia (2023) · Meta analysis · n=3779
Among these, ocrelizumab showed outstanding performance, with wCDP% of 72.6 at 96 weeks, while the proportions of rest of the drugs ranged between approximately 55-70%.
Vitamin supplementation in the treatment of optic neuritis: A systematic review and meta-analysis
Multiple sclerosis and related disorders (2025) · Meta analysis · n=2465
The effect of MD1003 (high-dose biotin), vitamin A, and vitamin D on retinal nerve fiber layer (RNFL) thickness from pooled results showed a mean change of 0.15 (SMD 0.15, 95 % CI, -0.33 to 0.64, I2 = 61 %, τ² = 0.11, p = 0.08), which was not significant.
High-dose biotin for multiple sclerosis: A systematic review and meta-analyses of randomized controlled trials
Multiple sclerosis and related disorders (2021) · Meta analysis · n=830
Pooled data for ITW25 at 12 to 15 months yielded statistical significance (RR 2.06; 95% CI 1.04-4.09; 2 trials; 796 participants; I2 = 0%) [moderate COE] favoring HDB among patients with PMS.
Marine n-3 Fatty Acids and Prevention of Cardiovascular Disease and Cancer
The New England journal of medicine (2019) · Rct · n=25871
During a median follow-up of 5.3 years, a major cardiovascular event occurred in 386 participants in the n-3 group and in 419 in the placebo group (hazard ratio, 0.92; 95% confidence interval [CI], 0.80 to 1.06; P=0.24).
Omega-3 fatty acids for intermittent claudication
The Cochrane database of systematic reviews (2024) · Meta analysis · n=1830
Omega-3 compared with a control may have little to no effect on ankle-brachial index (MD -0.02, 95% CI -0.08 to 0.04; 3 studies, 168 participants; very low-certainty evidence).
A systematic review and meta-analysis of the omega-3 fatty acids effects on brain-derived neurotrophic factor (BDNF)
Nutritional neuroscience (2024) · Meta analysis · n=587
The present systematic review and meta-analysis indicate the efficacy of omega-3 FAs in increasing the serum concentration of BDNF.
Based on multiple meta-analyses showing EPA-dominant formulas >1g/day most effective. Effects plateau around 2-2.5g. Adjunctive use with antidepressants shows better outcomes than monotherapy.
AI-estimated from published studies. Interpret as directional guidance.
Omega-3 has a higher evidence score (9/10 vs 5/10) and wins in 3 of 3 categories.
For prenatal support, Omega-3 has a higher relevance score (88 vs 50).
No known interactions between Biotin and Omega-3 have been documented in our database. However, always consult a healthcare provider before combining supplements.